-
Supreme Court Affirms State Authority on Medicaid Providers
South Carolina has the constitutional authority to block a provider from its Medicaid program without being vulnerable to lawsuits from recipients, the U.S. Supreme Court ruled in late June. Medina v. Planned Parenthood South Atlantic weighed in on whether Medicaid enrollees have a right to sue the state government if they believe their right to…
-
Grace-Marie Turner, Leading Force for Free Market Health Care, R.I.P.
A nationally respected voice for “individuals, not bureaucracies” in health care, Grace-Marie Turner never lost her belief that health reform was within the nation’s grasp as long as advocates stayed unified and persistent. Turner, aged 77, died on May 29, 2025, from brain cancer, according to the organization, CURE Policy. Turner was the founder and…
-
How Operation Warp Speed Helped Create RFK, Jr. – Commentary
Robert F. Kennedy Jr. has been Secretary of the Department of Health and Human Services (HHS) since mid-February. Despite being new to the job, Kennedy has made more statements to provoke public outrage than any HHS secretary in history. One example is when Kennedy once stated the measles vaccine (usually part of the combination measles-mumps-rubella…
-
Medicaid Is Not a Test Lab for Foreign Price Controls – Commentary
In a desperate bid to claim fiscal discipline without touching entitlements, President Donald Trump is pushing congressional Republicans to adopt a “most favored nation” (MFN) drug pricing model for Medicaid. This policy would tie Medicaid reimbursements to the lowest prices paid in other developed countries—countries where government officials dictate drug prices under threat of coercion,…
-
Fauci’s Fortune Doubled While He Led COVID-19 Policy
Anthony Fauci, the retired director of the National Institute of Allergy and Infectious Diseases (NIAID), doubled his fortune from $7.6 million to more than $15 million from January 2019 and the end of 2023, the watchdog group Open the Books reports. Fauci earned $3.5 million in his first year of retirement in 2023 alone. In…
-
Why Are Lower-Cost Biosimilars So Hard for Patients to Get?
The House Ways and Means Committee heard testimony on hindrances to the expansion of use of biosimilars, medications close in structure and function to a patented biologic medicine. Witnesses at the April 8 hearing told legislators biosimilars save patients and taxpayers money, that pharmacy benefit manager (PBM) middlemen often raise prices or limit availability for…
-
Pfizer’s COVID-19 Shot Linked to More Deaths Than Moderna’s, Study Finds
Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than those who received the Moderna shot, a new study of 1.47 million people found. Although all-cause mortality for either shot should have been the same, 230 more people per 100,000 who got the Pfizer jab died within the…
-
Best Way to End Medicaid Waste: Give Enrollees Cash – Commentary
In their paper titled “Leveraging the Medicaid Expansion,” David Hyman and Charles Silver write, “We propose that rather than adhering to Medicaid’s traditional structure, where states pay providers at unreasonably low rates for treating beneficiaries, expansion projects should be modeled on Social Security and the Earned Income Tax Credit, both of which distribute money that…
-
‘Designer Babies’ through IVF Raise Critics’ Ethical Concerns
Genetic screening technology now allows parents employing in vitro fertilization (IVF) to select for certain traits, allowing them to avoid passing on diseases or undesirable traits to their children. Orchid, a genetic screening company that bills itself as “the world’s most advanced whole genome screening for embryos during IVF,” allows parents essentially to customize children,…
-
HHS to Require Placebo-Controlled Trials for New Vaccines
The Department of Health and Human Services (HHS) announced it will enact a new policy requiring placebo-controlled trials for all new vaccines. The Washington Post reported on May 1 that HHS sent the outlet a statement that said, in part, “All new vaccines will undergo safety testing in placebo-controlled trials prior to licensure—a radical departure…
Latest Issue – December 2025
2025 Archived Editions: Jan, Feb, Mar, Apr, May, Jun, Aug, Sep, Oct, Dec
2024 Archived Editions: Jan, Feb, Mar, Apr, May, June Aug, Sept, Oct, Nov
2023 Archived Editions: Jan, Feb, Mar, Apr, May, Jun, Aug, Sep, Oct, Nov
2022 Archived Editions: Jan, Feb, Mar, Apr, May, July, Aug, Sept, Oct, Nov
2021 Archived Editions: Jan, Feb, Mar, Apr, May, June, July, Aug, Sept, Oct, Nov
2020 Archived Editions: Jan, Mar, Apr, Jun, Jul, Aug, Sep, Oct, Nov, Dec
For back issues and articles published before January 2020, click here.
